Biomed & Biotech Firms - Publicly Traded*

Dexcom Inc.

Company Website

5555 Oberlin Dr.
San Diego, CA 92121

Sourcebook Data

View all the companies in Biomed & Biotech Firms - Publicly Traded*

Dexcom Inc.

Market Cap as of 6/12/2015

$5,819,634,688

Market Cap as of 7/03/2014

$2,983,978,244

Market Cap as of 07/02/2013

$1,596,750,610

Market Cap as of 06/26/2012

$850,014,038

Market Cap as of 01/04/2012

$621,095,200

Market Cap as of 06/20/2011

$930,291,000

Market Cap as of 01/06/2011

$849,591,800

Exchange and Ticker Symbol

Nasdaq: DXCM

Fields of Research

Design, development, and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes

Major Products

FDA approved SEVEN, SEVEN PLUS

Executives

Terrance Gregg

  • Chief Executive Officer
  • Director

Kevin Sayer

  • Director
  • President

Patrick Murphy

  • Assist. General Counsel